Martin Curtis R, Cooley Ayorinde, Shakarchi Fatma, DeNaro Brittany B, Link Timothy, Zaunbrecher Nicholas, Shelby Christopher, Coleman Wyche T, LoBue Stephen
Department of Ophthalmology, Willis-Knighton Medical Center, Shreveport, USA.
Cureus. 2025 Aug 10;17(8):e89755. doi: 10.7759/cureus.89755. eCollection 2025 Aug.
To analyze the performance of trifocal intraocular lens (IOL) implantation in patients with high myopia vs patients with low-to-moderate myopia, with or without astigmatism.
A retrospective study examining trifocal IOL implantation in myopic patients was conducted at a single institution by one surgeon. Patients were followed on postoperative day 1, at one month, and at three months. Refraction was performed between the first and third months. A previously validated 10-question survey, scored from 0-10, was conducted one month after surgery. Patients were grouped into high myopia (≤ -5.00 diopters (D), axial length >25 mm) and low-to-moderate myopia (-1.00 to -5.00 D, axial length <25 mm). Exclusion criteria included high spherical aberration above 0.6, macular pathology, glaucoma, corneal disease, or scarring. Refractive outcomes, uncorrected distance visual acuity (UDVA), uncorrected near visual acuity (UNVA), and patient satisfaction surveys were compared.
A total of 72 eyes were included in the study (26 high myopes and 46 low-to-moderate myopes). The axial length and sphere were 26.67 ± 1.44 mm and -7.29 ± 2.80 D in the high myopia group vs 24.10 ± 1.11 mm and -2.38 ± 1.86 D in the low-to-moderate myopia group, p<0.001 and p<0.001, respectively. At one month postoperatively, UDVA, UNVA, and spherical equivalent (SE) revealed no difference between myopic groups. Residual refractive errors were ≤0.5 D in >90% of high (n=46) and low-to-moderate myopes (n=26). Comparing patients with >1.0 D of astigmatism in both high myopic (n=14) and low-to-moderate myopic groups (n=24) revealed no significant difference in sphere, cylinder, SE, monocular and binocular UDVA or UNVA, p>0.05. Overall patient satisfaction and the presence and severity of dysphotopsias were also similar between all groups, p>0.05.
Trifocal IOL may demonstrate high levels of visual performance and patient satisfaction in the presence of high axial myopia vs low-to-moderate myopia in patients with greater or less than 1.0 D of astigmatism in specific patients.
分析三焦点人工晶状体(IOL)植入术在高度近视患者与低度至中度近视患者(有或无散光)中的表现。
由一名外科医生在单一机构进行了一项回顾性研究,该研究对近视患者的三焦点IOL植入术进行了检查。在术后第1天、1个月和3个月对患者进行随访。在第1个月至第3个月之间进行验光。术后1个月进行了一项先前经验证的包含10个问题的调查,评分范围为0至10分。患者被分为高度近视组(≤ -5.00屈光度(D),眼轴长度>25 mm)和低度至中度近视组(-1.00至 -5.00 D,眼轴长度<25 mm)。排除标准包括高于0.6的高球差、黄斑病变、青光眼、角膜疾病或瘢痕形成。比较了屈光结果、未矫正远视力(UDVA)、未矫正近视力(UNVA)和患者满意度调查。
该研究共纳入72只眼(26只高度近视患者和46只低度至中度近视患者)。高度近视组的眼轴长度和球镜度数分别为26.67 ± 1.44 mm和 -7.29 ± 2.80 D,而低度至中度近视组分别为24.10 ± 1.11 mm和 -2.38 ± 1.86 D,p值分别<0.001和<0.001。术后1个月,UDVA、UNVA和等效球镜度(SE)在近视组之间无差异。超过90%的高度近视患者(n = 46)和低度至中度近视患者(n = 26)的残余屈光不正≤0.5 D。比较高度近视组(n = 14)和低度至中度近视组(n = 24)中散光>1.0 D的患者,发现球镜度、柱镜度、SE、单眼和双眼UDVA或UNVA均无显著差异,p>0.05。所有组之间患者的总体满意度以及眩光的存在和严重程度也相似,p>0.05。
在特定患者中,对于存在1.0 D以上或以下散光的高度轴性近视患者与低度至中度近视患者,三焦点IOL可能表现出较高的视觉性能和患者满意度。